Jo-Fan Chang

Nuclear proteomics with XRCC3 knockdown to reveal the development of doxorubicin-resistant uterine cancer.

H. Chou, Y. Lo, H. Chan, 2014, Toxicological sciences : an official journal of the Society of Toxicology.

Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

H. Chan, Szu-Ting Lin, L. Wang, 2015, Cellular and Molecular Life Sciences.

PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

H. Chan, Szu-Ting Lin, L. Wang, 2015, Cellular and Molecular Life Sciences.

Identification of up- and down-regulated proteins in doxorubicin-resistant uterine cancer cells: reticulocalbin-1 plays a key role in the development of doxorubicin-associated resistance.

Chi-Chen Lin, H. Chou, Y. Lo, 2014, Pharmacological research.

Mitochondrial proteomics with siRNA knockdown to reveal ACAT1 and MDH2 in the development of doxorubicin-resistant uterine cancer

Chia-Hao Chan, Shing-Jyh Chang, H. Chou, 2015, Journal of cellular and molecular medicine.

Erratum to: PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

H. Chan, Szu-Ting Lin, L. Wang, 2015, Cellular and Molecular Life Sciences.

Phosphodiesterase Type 5 (PDE5) Inhibitors Sensitize Topoisomerase II Inhibitors in Killing Prostate Cancer Through PDE5-Independent Impairment of HR and NHEJ DNA Repair Systems

J. Guh, Shih-Ping Liu, Chia-Chun Yu, 2019, Front. Oncol..

PGRMC1 contributes to doxorubicin-induced chemoresistance in MES-SA uterine sarcoma

H. Chan, Szu-Ting Lin, L. Wang, 2015, Cellular and Molecular Life Sciences.